ArticleJournal of proteome research2020

Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV-2.

William R Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.